Liposome–exosome hybrids for <i>in situ</i> detection of exosomal miR-1246 in breast cancer

Abstract

particles per mL. This strategy could not only be used to detect serum exosomal miR-1246 in breast cancer patients but also to distinguish early form advanced disease. This strategy can be exploited in future exosomal miRNA analyses.